| P2093 | author name string | Gerber GS | |
| P2860 | cites work | A Placebo-controlled Double-blind Study of the Effect of Phenoxybenzamine in Benign Prostatic Obstruction | Q28295255 |
| | The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association | Q33846043 |
| | The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group | Q33970656 |
| | Late renal failure due to prostatic outflow obstruction: a preventable disease | Q35707598 |
| | Outpatient visual laser-assisted prostatectomy under local anesthesia | Q36673996 |
| | Lasers in the treatment of benign prostatic hyperplasia | Q36677517 |
| | Reproducibility of uroflowmetry variables in elderly males | Q38154742 |
| | Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States | Q38508926 |
| | A Randomized, Placebo-Controlled Multicenter Study of the Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic Hyperplasia | Q38533290 |
| | Doxazosin in men with lower urinary tract symptoms: urodynamic evaluation at 15 months | Q39454135 |
| | The flow rate nomogram: II. Clinical correlation. | Q39572562 |
| | Classification of alpha 1-adrenoceptor subtypes | Q40369827 |
| | Finasteride | Q40384709 |
| | Benign prostatic hyperplasia. Medical and minimally invasive treatment options | Q40395290 |
| | Public health perspective: the health policy implications of screening for prostate cancer. | Q40636347 |
| | Prostatism: benign prostatic hyperplasia | Q41013396 |
| | The role of urodynamic study in the evaluation and management of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia | Q41204948 |
| | Improved indication and followup in transurethral resection of the prostate using the computer program CLIM: a prospective study | Q44392285 |
| | The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group | Q45335490 |
| | Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association | Q45788591 |
| | High-energy transurethral microwave thermotherapy: a thermoablative treatment for benign prostatic obstruction. | Q51563976 |
| | Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: durability of response. | Q53367864 |
| | Urodynamic and Clinical Effects of Terazosin Therapy in Patients with Symptomatic Benign Prostatic Hyperplasia | Q57912172 |
| | Serial residual volumes in men with prostatic hypertrophy | Q69052591 |
| | Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients | Q69483532 |
| | Uroflowmetry in asymptomatic elderly males | Q69614115 |
| | High flow infravesical obstruction in men: symptomatology, urodynamics and the results of surgery | Q70376702 |
| | Differential diagnosis of prostatism: A 12-year retrospective analysis of symptoms, urodynamics and satisfaction with therapy | Q71083153 |
| | An observational urodynamic evaluation of men with lower urinary tract symptoms treated with doxazosin | Q71180132 |
| | Do reported micturition symptoms on the American Urological Association Questionnaire correlate with 24-hour home uroflowmetry recordings? | Q71566680 |
| | The Nature of Prostate Cancer Detected Through Prostate Specific Antigen Based Screening | Q71651684 |
| | Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia. Terazosin Research Group | Q71678289 |
| | Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia | Q71688010 |
| | Tamsulosin, a selective alpha 1c-adrenoceptor antagonist: a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH). The European Tamsulosin Study Group | Q71724801 |
| | The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists | Q71926905 |
| | The effect of finasteride on prostate‐specific antigen in men with benign prostatic hyperplasia | Q72068832 |
| | Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group | Q72081383 |
| | Comparison of aua symptom index in unselected males and females between fifty-five and seventy-nine years of age | Q72087018 |
| | How Reliable is a Single Measurement of Urinary Flow in the Diagnosis of Obstruction in Benign Prostatic Hyperplasia? | Q72097024 |
| | A comparison of quality of life with patient reported symptoms and objective findings in men with benign prostatic hyperplasia. The Department of Veterans Affairs Cooperative Study of transurethral resection for benign prostatic hyperplasia | Q72098623 |
| | Urinary flow rates and voiding pressures in elderly men living in a community | Q72433471 |
| | Analysis of presenting symptoms in prostatism | Q72736603 |
| | The development of human benign prostatic hyperplasia with age | Q72743475 |
| | Serum creatinine measurements in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia | Q73328616 |
| | Urodynamics in prostatism. I. Prognostic value of uroflowmetry | Q93511835 |
| P433 | issue | 2 | |
| P921 | main subject | prostatic hypertrophy | Q506659 |
| P304 | page(s) | 317-331 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | Clinics in geriatric medicine | Q26842145 |
| P1476 | title | Benign prostatic hyperplasia in older men | |
| P478 | volume | 14 | |